Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03615573 · ClinicalTrials.gov registry record
Survey Study: Financial Impact of Breast Cancer Treatment
A clinical trial, sponsored by The Guthrie Clinic.
- Completed
- Registry status
- 103
- Enrollment target
NCT03615573: Completed study, sponsored by The Guthrie Clinic.
NCT03615573 is a clinical trial that has completed, run by The Guthrie Clinic. The registered enrollment target is 103 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03615573 has completed, sponsored by The Guthrie Clinic.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
A survey study to evaluate the financial impact of breast cancer as self-reported by breast cancer patients over a period of 1 year. The study will also look at the health insurance literacy and patient's utilization of support services.
Primary Outcome
Will evaluate the change in Comprehensive Score for Financial Toxicity (COST-FACIT) measurements from baseline to 1 year follow up. This survey consists of 14 questions related to finances.Responses include 5 options with lower scores representing worse outcomes. Scores at 1 year will be compared to baseline scores.
Interventions
- OTHER Quality of Life Surveys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2024-02-10 |
What the finished NCT03615573 record still lists
NCT03615573 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Quality of Life Surveys is the first listed.
NCT03615573 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03615573 about?
NCT03615573 is a clinical study titled "Survey Study: Financial Impact of Breast Cancer Treatment". A survey study to evaluate the financial impact of breast cancer as self-reported by breast cancer patients over a period of 1 year. The study will also look at the health insurance literacy and patient's utilization of support services.
What is the current status of trial NCT03615573?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2018-09-04. Estimated completion is 2024-02-10.
What interventions are being tested in trial NCT03615573?
The interventions under investigation include: Quality of Life Surveys (OTHER).
Who is sponsoring clinical trial NCT03615573?
This trial is sponsored by The Guthrie Clinic, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI